naltrexone and Polycystic Ovary Syndrome

naltrexone has been researched along with Polycystic Ovary Syndrome in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (9.09)	18.7374
1990's	12 (54.55)	18.2507
2000's	5 (22.73)	29.6817
2010's	3 (13.64)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chatzis, P; Dinas, K; Makris, V; Pratilas, GC; Sotiriadis, A; Tziomalos, K	1
Ahmed, MI; Duleba, AJ; El Shahat, O; Ibrahim, ME; Salem, A	1
Falbo, A; Palomba, S; Zullo, F	1
Hadžiomerović-Pekić, D; Mattle, V; Moeller, K; Seeber, BE; Weiss, JM; Wildt, L	1
Ejtemaeimehr, Sh; Fatemeh, A; Mohammadi, A; Naghizadeh, MM; Zangeneh, FZ	1
Cagnacci, A; Paoletti, AM	1
Guido, M; Lanzone, A; Romualdi, D	1
Caruso, A; Ciampelli, M; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S	1
Cagnacci, A; Falqui, A; Melis, GB; Paoletti, AM; Soldani, R	1
Franks, S; Gilling-Smith, C	1
Caruso, A; Cucinelli, F; Fulghesu, AM; Lanzone, A; Mancuso, S	1
Apa, R; Caruso, A; Cutillo, G; Fulghesu, AM; Lanzone, A; Mancuso, S	1
Caruso, A; Ciampelli, M; Cucinelli, F; Fulghesu, AM; Lanzone, A; Mancuso, S	1
Caruso, A; Ciampelli, M; Cucinelli, F; Fortini, A; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S	1
Caruso, A; De Marinis, L; Fulghesu, AM; Lanzone, A; Mancini, A; Pavone, V; Valle, D; Villa, P	1
Caruso, A; Ciampelli, M; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S; Murgia, F	1
Apa, R; Caruso, A; Ciampelli, M; Fulghesu, AM; Guido, M; Lanzone, A; Mancuso, S; Murgia, F; Pavone, V	1
De Marinis, L; Fulghesu, AM; Lanzone, A; Mancini, A; Mancuso, S; Pavone, V; Valle, D; Villa, P	1
Bersi, C; Fruzzetti, F; Genazzani, AR; Parrini, D; Ricci, C	1
Armeanu, MC; Berkhout, GM; Schoemaker, J	1
Brawer, JR; Carriere, PD; Farookhi, R	1
Bittle, JB; Givens, JR; Howes, JF; Karas, JG; Kitabchi, AE; Kurtz, BR; Mitchell, JA	1

Reviews

4 review(s) available for naltrexone and Polycystic Ovary Syndrome

Article	Year
The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome. Folia medica, 2018, Dec-01, Volume: 60, Issue:4 Topics: Androgens; Anti-Obesity Agents; Bupropion; Drug Combinations; Female; Humans; Insulin Resistance; Liraglutide; Naltrexone; Obesity; Orlistat; Polycystic Ovary Syndrome; Weight Loss	2018
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance. Current opinion in obstetrics & gynecology, 2009, Volume: 21, Issue:6 Topics: Acetylcysteine; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bromocriptine; Clomiphene; Dexamethasone; Drug Resistance; Female; Fertility Agents, Female; Free Radical Scavengers; Glucocorticoids; Gonadotropin-Releasing Hormone; Gonadotropins; Hormone Antagonists; Humans; Hypoglycemic Agents; Infertility, Female; Laparoscopy; Metformin; Naltrexone; Narcotic Antagonists; Octreotide; Ovary; Ovulation Induction; Polycystic Ovary Syndrome	2009
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities. Current pharmaceutical design, 2006, Volume: 12, Issue:8 Topics: Clinical Trials as Topic; Endorphins; Female; Humans; Hyperinsulinism; Insulin Resistance; Menopause; Naloxone; Naltrexone; Narcotic Antagonists; Obesity; Polycystic Ovary Syndrome	2006
Advances in induction of ovulation. Current opinion in obstetrics & gynecology, 1994, Volume: 6, Issue:2 Topics: Buserelin; Clinical Trials as Topic; Clomiphene; Drug Administration Schedule; Drug Resistance; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Naltrexone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome	1994

Trials

7 trial(s) available for naltrexone and Polycystic Ovary Syndrome

Article	Year
Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome. Fertility and sterility, 2010, Volume: 94, Issue:6 Topics: Adolescent; Adult; Androgen Antagonists; Antineoplastic Agents; Contraceptives, Oral; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hyperinsulinism; Hypoglycemic Agents; Metformin; Naltrexone; Neoadjuvant Therapy; Polycystic Ovary Syndrome; Prednisolone; Young Adult	2010
Prolonged opioid blockade with naltrexone and luteinizing hormone modifications in women with polycystic ovarian syndrome. Fertility and sterility, 1994, Volume: 62, Issue:2 Topics: Adult; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Naltrexone; Narcotic Antagonists; Placebos; Polycystic Ovary Syndrome; Reference Values; Time Factors	1994
Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients. Metabolism: clinical and experimental, 1997, Volume: 46, Issue:5 Topics: Adult; Female; Glucose Tolerance Test; Growth Hormone-Releasing Hormone; Hormones; Human Growth Hormone; Humans; Hyperandrogenism; Insulin; Insulin Secretion; Naltrexone; Narcotic Antagonists; Obesity; Polycystic Ovary Syndrome; Reference Values; Time Factors	1997
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:5 Topics: Adult; Androgens; Estradiol; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Kinetics; Leuprolide; Luteinizing Hormone; Naltrexone; Narcotic Antagonists; Opioid Peptides; Ovary; Polycystic Ovary Syndrome; Steroids	1998
Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism. Fertility and sterility, 1999, Volume: 71, Issue:1 Topics: Adult; Area Under Curve; Female; Glucose Tolerance Test; Human Growth Hormone; Humans; Hyperinsulinism; Insulin; Naltrexone; Narcotic Antagonists; Obesity; Polycystic Ovary Syndrome	1999
Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertility and sterility, 2002, Volume: 77, Issue:5 Topics: Adult; Androgens; Blood Glucose; Body Mass Index; Drug Administration Schedule; Endocrine Glands; Fasting; Female; Gonadotropins; Humans; Hydrocortisone; Insulin; Insulin Resistance; Menstrual Cycle; Naltrexone; Narcotic Antagonists; Obesity; Polycystic Ovary Syndrome; Time Factors	2002
Reduction of hyperinsulinemia and insulin resistance by opiate receptor blockade in the polycystic ovary syndrome with acanthosis nigricans. The Journal of clinical endocrinology and metabolism, 1987, Volume: 64, Issue:2 Topics: Acanthosis Nigricans; Adolescent; Adult; Blood Glucose; Female; Humans; Insulin; Insulin Resistance; Naloxone; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome	1987

Other Studies

11 other study(ies) available for naltrexone and Polycystic Ovary Syndrome

Article	Year
Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. Human reproduction (Oxford, England), 2008, Volume: 23, Issue:11 Topics: Adolescent; Adult; Analgesics, Opioid; Body Mass Index; Clomiphene; Drug Resistance; Estrogen Antagonists; Female; Humans; Infertility, Female; Luteinizing Hormone; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate	2008
The role of opioid system and its interaction with sympathetic nervous system in the processing of polycystic ovary syndrome modeling in rat. Archives of gynecology and obstetrics, 2011, Volume: 283, Issue:4 Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Clonidine; Disease Models, Animal; Estradiol; Female; Gonadal Steroid Hormones; Naltrexone; Narcotic Antagonists; Ovary; Polycystic Ovary Syndrome; Rats; Rats, Wistar; Receptors, Opioid; Sympathetic Nervous System; Yohimbine	2011
Long-term response to naltrexone in polycystic ovary syndrome? Fertility and sterility, 2003, Volume: 79, Issue:3 Topics: Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome	2003
Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome. Human reproduction (Oxford, England), 1994, Volume: 9, Issue:12 Topics: Adrenocorticotropic Hormone; Androgens; Dexamethasone; Female; Humans; Insulin; Insulin Secretion; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome; Stimulation, Chemical	1994
Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease. Obstetrics and gynecology, 1993, Volume: 82, Issue:2 Topics: Adult; Endorphins; Female; Glucose Tolerance Test; Gonadal Steroid Hormones; Humans; Hyperinsulinism; Insulin; Naloxone; Naltrexone; Obesity; Polycystic Ovary Syndrome; Time Factors	1993
Long-term naltrexone treatment normalizes the pituitary response to gonadotropin-releasing hormone in polycystic ovarian syndrome. Fertility and sterility, 1993, Volume: 59, Issue:4 Topics: Adolescent; Adult; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Naltrexone; Pituitary Gland; Polycystic Ovary Syndrome	1993
Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome: relationship with insulin and luteinizing hormone secretion. The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:12 Topics: Adult; Endorphins; Female; Glucose Tolerance Test; Humans; Hyperinsulinism; Insulin; Insulin Secretion; Luteinizing Hormone; Naltrexone; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin	1995
Effect of opioid blockade on insulin metabolism in polycystic ovarian disease. Human reproduction (Oxford, England), 1995, Volume: 10, Issue:9 Topics: Adolescent; Adult; Blood Glucose; Body Mass Index; C-Peptide; Female; Glucose Tolerance Test; Humans; Insulin; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome	1995
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease. Metabolism: clinical and experimental, 1998, Volume: 47, Issue:2 Topics: Adolescent; Adult; C-Peptide; Female; Glucose; Humans; Hyperinsulinism; Insulin Resistance; Naltrexone; Opioid Peptides; Polycystic Ovary Syndrome	1998
Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment. Fertility and sterility, 1992, Volume: 57, Issue:4 Topics: Activity Cycles; Adult; Amenorrhea; Anorexia Nervosa; Estradiol; Female; Follicle Stimulating Hormone; Humans; Hypothalamus; Luteinizing Hormone; Naltrexone; Polycystic Ovary Syndrome; Prospective Studies; Radioimmunoassay	1992
The role of aberrant hypothalamic opiatergic function in generating polycystic ovaries in the rat. Canadian journal of physiology and pharmacology, 1989, Volume: 67, Issue:8 Topics: Animals; Endorphins; Estrus; Female; Follicle Stimulating Hormone; Hypothalamus; Luteinizing Hormone; Naltrexone; Ovary; Pituitary Gland, Anterior; Polycystic Ovary Syndrome; Prolactin; Rats; Rats, Inbred Strains; Receptors, LHRH; Up-Regulation	1989